Academic Highlights June 15, 1998

Atypical Antipsychotic Agents in the Treatment of Schizophrenia and Other Psychiatric Disorders. Part II: Special Considerations

Stephen R. Marder, M.D.; Dilip V. Jeste, M.D.; Joseph P. McEvoy, M.D.

J Clin Psychiatry 1998;59(6):322-328

Article Abstract

Click to enlarge page

Indications for atypical antipsychotics other than schizophrenia so far have included bipolar disorder, major depression, schizoaffective disorder, dementia, delirium, obsessive-compulsive disorder, Tourette’s syndrome, and mental retardation, Dr. Prakash S. Masand reported. In 1997, only 38% of risperidone prescriptions in the United States were for the treatment of schizophrenia, while 20% were for bipolar disorder, 11% for dementia, and the rest (31%) for the other disorders listed above.